Dayno Jeffrey M. — SEC Form 4 filings
SEC reporting owner CIK 1615993. 5 Form 4 filings on record with FilingPulse; latest filed 2026-01-26.
Transaction summary — filings shown
Covers all 5 filings on record, filed 2024-01-26 to 2026-01-26. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 3 legs across 2 filings — 45,226 shares, $1,814,348 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 21.
- Largest priced transaction: sale of 20,000 shares @ $40.11 ($802,146) in Harmony Biosciences Holdings, Inc., filed 2025-12-17.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Harmony Biosciences Holdings, Inc. (HRMY) | PRESIDENT, CEO, Director | 5 | — | 3 legs · 45,226 sh · $1,814,348 | 21 |
Form 4 filings — Dayno Jeffrey M.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-01-26 | 4 | Harmony Biosciences Holdings, Inc. (HRMY) | Option exercise (M): 10,500 @ $0 · Tax withholding (F): 4,785 @ $36.82 · Option exercise (M): 13,000 @ $0 · Tax withholding (F): 5,654 @ $36.82 · Grant/award (A): 184,600 (derivative) @ $0 · Grant/award (A): 52,900 (derivative) @ $0 · +2 more | EDGAR |
| 2025-12-17 | 4 | Harmony Biosciences Holdings, Inc. (HRMY) | Option exercise (M): 20,000 @ $8.22 · Sale (S): 20,000 @ $40.11 · Sale (S): 5,933 @ $40.11 · Option exercise (M): 20,000 (derivative) @ $0 | EDGAR |
| 2025-01-28 | 4 | Harmony Biosciences Holdings, Inc. (HRMY) | Option exercise (M): 10,500 @ $0 · Tax withholding (F): 4,567 @ $38.01 · Option exercise (M): 10,500 (derivative) @ $0 · Grant/award (A): 180,000 (derivative) @ $0 · Grant/award (A): 52,000 (derivative) @ $0 | EDGAR |
| 2025-01-23 | 4 | Harmony Biosciences Holdings, Inc. (HRMY) | Option exercise (M): 19,293 @ $8.22 · Sale (S): 19,293 @ $40.13 · Option exercise (M): 3,470 (derivative) @ $0 · Option exercise (M): 6,086 (derivative) @ $0 · Option exercise (M): 9,737 (derivative) @ $0 | EDGAR |
| 2024-01-26 | 4 | Harmony Biosciences Holdings, Inc. (HRMY) | Grant/award (A): 202,250 (derivative) @ $0 · Grant/award (A): 42,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1615993 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →